Chicago-based Linden has so far gathered $208 million for
Linden invests in the North American health care and life sciences industries, typically in lower middle-market companies with revenues of $25 million to $300 million. Fund II is earmarked for eight to 10 platform investments, plus add-ons.
Deal sizes for the health care shop span the chasm from $10 million to $2 billion, while specific industry niches include animal health products, health care services, hospital products and life science equipment.
The team includes partners and founders Mary Beth Berkes, Anthony Davis, Eric Larson and Brian Miller. Linden has eight investment professionals and 12 operating partners that assist portfolio companies and vet possible acquisition targets.
Backers of the firm’s $200 million freshman fund,